Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Nelarabine

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Arranon

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 39,437Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Shorla Oncology Gets FDA Nod For Bigger Nelarabine Vial
    Shorla Oncology Gets FDA Nod For Bigger Nelarabine Vial

    28 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260127385856/en/Shorla-Oncology-Announces-U.S.-FDA-Approval-of-Larger-Vial-Size-for-Nelarabine-Intravenous-Administration-for-the-Treatment-of-T-cell-Acute-Lymphoblastic-Leukemia-and-T-cell-Lymphoblastic-Lymphoma

    BUSINESSWIRE
    28 Jan 2026
    Share Share
    Enforcement Report - Week of March 12, 2025
    Enforcement Report - Week of March 12, 2025

    12 Mar 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-12-2025-99448.pdf

    FDA
    12 Mar 2025
    Share Share
    XGen Pharm`s Generics Nelarabine Receives Approval in US
    XGen Pharm`s Generics Nelarabine Receives Approval in US

    05 Sep 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216510

    FDA
    05 Sep 2024
    Share Share
    Alembic Nelarabine injection gets FDA final approval
    Alembic Nelarabine injection gets FDA final approval

    05 Aug 2024

    // ECONOMICSTIMES

    https://health.economictimes.indiatimes.com/news/pharma/drug-approvals-launches/alembic-nelarabine-injection-gets-fda-final-approval/112225170?utm_source=category_listing&utm_medium=sectionListing

    ECONOMICSTIMES
    05 Aug 2024
    Share Share
    Alembic Pharmaceutical`s Generics Nelarabine Receives Approval in US
    Alembic Pharmaceutical`s Generics Nelarabine Receives Approval in US

    01 Aug 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218554

    FDA
    01 Aug 2024
    Share Share
    Gland Pharma`s Generic Nelarabine Receives Approval in the U.S.
    Gland Pharma`s Generic Nelarabine Receives Approval in the U.S.

    03 Jan 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212605

    FDA
    03 Jan 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.